↓ Skip to main content

Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study

Overview of attention for article published in BMC Rheumatology, January 2024
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
8 X users

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study
Published in
BMC Rheumatology, January 2024
DOI 10.1186/s41927-024-00374-x
Pubmed ID
Authors

Atsuko Tsujii, Kentaro Isoda, Maiko Yoshimura, Akihiko Nakabayashi, Dong-Seop Kim, Tatsuya Tamada, Kurumi Yamamoto, Shiro Ohshima

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 33%
Student > Ph. D. Student 2 22%
Researcher 2 22%
Student > Bachelor 1 11%
Unknown 1 11%
Readers by discipline Count As %
Medicine and Dentistry 4 44%
Linguistics 2 22%
Immunology and Microbiology 1 11%
Unknown 2 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2024.
All research outputs
#7,047,281
of 25,420,980 outputs
Outputs from BMC Rheumatology
#133
of 259 outputs
Outputs of similar age
#77,424
of 292,369 outputs
Outputs of similar age from BMC Rheumatology
#5
of 7 outputs
Altmetric has tracked 25,420,980 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 259 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,369 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.